Onconetix, Inc.
Pharmaceutical company · Cincinnati, Ohio, United States · Nasdaq: ONCO
Onconetix, Inc. is a pharmaceutical company headquartered in Cincinnati, Ohio, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker ONCO. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2025.
Onconetix at a glance
What does Onconetix do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $13 million sold (2025).
Frequently asked questions about Onconetix
Where is Onconetix headquartered?
Onconetix, Inc. is headquartered in Cincinnati, Ohio, United States.
What does Onconetix do?
Onconetix, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Onconetix a public company?
Yes. Onconetix, Inc. trades on Nasdaq under the ticker ONCO.
When was Onconetix founded?
The earliest incorporation on record for Onconetix, Inc. is in 2018, according to public company registers.
Similar companies
- Procter & GambleCincinnati, Ohio, United States
- Eikonoklastes Therapeutics, Inc.Cincinnati, Ohio, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences